GMTs were statistically significantly lower for an HPV-@ / @/@/@ AS@ vaccine containing @/@/@ / @ g VLPs for both anti-HPV-@ and anti-HPV-@ antibodies , and for an HPV-@ / @/@/@ AS@ vaccine containing @/@/@ / @ g VLPs for anti-HPV-@ antibodies .